A mass flow controller that is silent, fast and cost-effective

Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...

Wusson Accelerator AB

Xbrane tar in 240 miljoner – satsar vidare på biosimilarprojekt

Biosimilarutvecklaren Xbrane Biopharma tar in 240 miljoner kronor i en riktad nyemission, som var övertecknad.

Abbvie i miljardaffär – tar sikte på in vivo CAR-T

Abbvie har tecknat avtal om att förvärva det kliniska biotechbolaget Capstan Therapeutics för upp till 2,1 miljarder dollar och får därmed tillgång till bland a...

A new scientific event in Gothenburg

Life Science Sweden is holding an event in Gothenburg for the first time.

Novo Nordisk appoints Mike Doustdar as new CEO

The Danish pharmaceutical giant Novo Nordisk has appointed Mike Doustdar as its new CEO. At the same time, the company announced it was lowering its forecasts –...

AI automates testing of implant coatings

The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect coated implants.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

“I am driven by the desire to develop a product that can be sold worldwide”

Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forw...

Optimera flödeshanteringen med Brooks Expert Support Tool (BEST)

Brooks Instrument erbjuder ett kraftfullt verktyg för dig som arbetar med digitala massflödesmätare och massflödesregulatorer. Med den Windows-baserade mjukvara...

Nordic Regulatory experts: Improving biotech chances of Succ

Why is it that so many biotech companies fail? And what are the tools needed to change that fact?

GSK i stort Kinasamarbete – ska utveckla ett dussin nya läkemedel

Den brittiska läkemedelsjätten GSK har tecknat ett stort samarbetsavtal med kinesiska Hengrui Pharma om utveckling av upp till 12 nya läkemedel.

Study names with an attitude – more important than you might think

Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.

Acne medication may be the solution when hair starts falling out

A treatment originally developed for acne has shown remarkable Phase III results in a completely different area: male-pattern hair loss.

GSK acquires oncology research company

GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.

ALS – When the body has given up, but the brain persists

with the outside world can continue. “It’s their window to the world,” says ALS researcher Caroline Ingre.

Miljardstämning mot BMS – anklagas för att avsiktligt ha försenat läkemedel

En amerikansk domare avvisar kraven från Bristol Myers om att avskriva en stämning på 6,7 miljarder dollar, där bolaget anklagas för att lurat aktieägare genom ...

Björn Arvidsson ska driva forskning och innovation i Region Uppsala

Life science-profilen Björn Arvidsson har utsetts till forsknings- och innovationsdirektör för Region Uppsala.

Får grönt ljus för global studie – ”En betydande katalysator för Cereno”

Det Mölndalsbaserade forskningsbolaget Cereno Scientific har fått klartecken av FDA att inleda en global fas IIb-studie inom hjärt- och lungsjukdomen PAH, pulmo...

40,000 DNA extractions daily

, customers in the seed industry can collect DNA from up to 40,000 samples per day.

Budstrid om narkolepsibolag avgjord – Lundbeck drar sig ur

En uppmärksammad budstrid om det irländska biotechbolaget Avadel Pharmaceuticals har slutat med att danska Lundbeck kastar in handduken.

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

To build trust, one must be able to say “I don’t know” – whether human or AI

Will AI strengthen or break down trust? It depends on whether we can understand and accept its limitations, and our own, writes Sarah Lidé in a column.